Match tier Institution-verified
Presence Current · Arkansas
Last published 2025
Sources Institutional record
Refreshed 2026-08-06
Sreelakshmi Ravula profile photo

Sreelakshmi Ravula

Sourced from institutional research profiles (UAMS TRI or ARA).

Associate Professor

Faculty Researcher

Internal Medicine, College of Medicine

3 h-index 8 pubs 735 cited

  • Humans
  • Complement C3
  • Female
  • Cardiac Surgical Procedures
  • Vitamin D-Binding Protein
  • Biomarkers
  • Acute Kidney Injury
  • Acidosis
  • Liver Diseases
  • Liver Failure
  • Renal Insufficiency, Chronic
  • Immunophenotyping
  • Aged
  • Animals
  • Male

Edit your profile

Biography and Research Information

OverviewAI-generated summary

Sreelakshmi Ravula's research focuses on critical care medicine, with a particular emphasis on acute kidney injury (AKI) and its management. Her work investigates predictors of adverse outcomes in patients with AKI, including studies on urinary complement C3 and vitamin D-binding protein. Ravula also explores specific clinical challenges, such as unresolving hypokalemia and dialysis-associated reactions.

Her publications demonstrate an interest in various aspects of nephrology and critical care, including the role of acidosis in chronic kidney and liver disease, and interventions for AKI, such as targeted intra-abdominal pressure reduction. Ravula collaborates with researchers at the University of Arkansas for Medical Sciences, including Joseph H. Holthoff and Omar Dodin, on shared publications. Her scholarship metrics include an h-index of 3, with 8 total publications cited 735 times.

Metrics

  • h-index: 3
  • Publications: 8
  • Citations: 735

Selected Publications

  • Perfusion Under Pressure: Reversing Anuric AKI with Targeted Intra-Abdominal Pressure (IAP) Reduction (2025)
    Journal of the American Society of Nephrology DOI OpenAlex
  • A Case of Unresolving Hypokalemia (2024)
    Journal of the American Society of Nephrology 1 citation DOI OpenAlex
  • A Curious Case of Dialysis-Associated Reaction (2024)
    Journal of the American Society of Nephrology DOI OpenAlex
  • Urinary Complement C3 and Vitamin D-Binding Protein Predict Adverse Outcomes in Patients with Acute Kidney Injury after Cardiac Surgery (2024)
    ˜The œNephron journals/Nephron journals 3 citations DOI OpenAlex
  • No Good Deed: Acidosis in Chronic Kidney and Liver Disease (2023)
    Journal of Renal Nutrition 3 citations DOI OpenAlex

Grants & Funding

As listed on this researcher's institutional profile.

  • A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PARALLEL-GROUP, ACTIVE CONTROL STUDY OF THE EFFICACY AND SAFETY OF SPARSENTAN FOR THE TREATMENT OF IMMUNOGLOBULIN A NEPHROPATHY (IRB 262333) Travere Therapeutics Principal Investigator
  • Efficacy of Belimumab and Rituximab Compared to Rituximab Alone for the Treatment of Primary Membranous Nephropathy (IRB 274955) NIH/Nat. Inst. of Allergy & Infectious Diseases via Benaroya Research Institute at Virginia Mason Principal Investigator

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics